- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT04053179
Validation of a Connected Patch, an Alternative to Conventional Monitoring
연구 개요
상세 설명
When patients operated on outside intensive care or intensive care units are hospitalized, vital signs are collected intermittently by various conventional devices. During the follow-up period of these patients, it is possible that abnormal vital signs that may identify clinical deterioration may appear a few minutes to a few hours before a serious adverse event (infection etc.) occurs. These signals often go unnoticed due to infrequent monitoring.
The establishment of teams to ensure a rapid response would improve the safety of hospitalized patients for whom the detection of abnormal vital signs predictive of clinical deterioration would generate an alarm. This system is based on the identification of patients at risk and the rapid intervention of the team.
One of the crucial issues is therefore the speed of the alarm and its reliability.
The evolution of electronic technology offers the possibility of using inexpensive portable devices (connected patches) that can provide information on vital signs in real time. Vital signs collected by these devices could be analyzed to predict clinical deterioration prior to hospital staff visits, especially at night and on weekends when staffing levels are generally lower.
The connected patch used in this research is the Scaléo Médical company's device "myAngel VitalSigns". The long-term objective would be to be able to use this connected patch in surgical departments to detect early a complication, particularly of a cardiovascular or respiratory nature, and therefore to treat it without wasting time. However, it has not been validated in a hospital setting; that is the purpose of the project.
The objective of this research is therefore to validate Scaléo Médical's connected patch in different locations: post-interventional surveillance room that approaches a conventional hospital room, operating room where artifacts are numerous.
연구 유형
단계
- 해당 없음
연락처 및 위치
연구 장소
-
-
-
Suresnes, 프랑스, 92150
- Hôpital Foch
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- patient over 18 and under 85 years of age
- patient requiring general anesthesia for extra-thoracic surgery
- the patient's position during the operation is in supine position only
- patient affiliated to or benefiting from social security, excluding State Medical Assistance
- patient with written consent
Exclusion Criteria:
- pregnant or breastfeeding patients
- patients known to have severe skin reactions to adhésives
- patient whose surgical procedure prevents the patch from being placed (intervention on the thorax)
- patients deprived of their liberty or under guardianship
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 다른
- 할당: 해당 없음
- 중재 모델: 단일 그룹 할당
- 마스킹: 없음(오픈 라벨)
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
---|---|
실험적: 연결된 패치 검증
|
연결된 패치를 사용하여 혈압, 심박수, 호흡수, 동맥 산소포화도 및 온도를 수집합니다.
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
---|---|---|
Concordance of blood pressure value measured by 2 different devices after surgery
기간: 36 hours maximum after the surgery
|
Comparison between blood pressure measured by conventional medical monitoring device and by connected patch
|
36 hours maximum after the surgery
|
Concordance of heart rate value measured by 2 different devices after surgery
기간: 36 hours maximum after the surgery
|
Comparison between heart rate measured by conventional medical monitoring device and by connected patch
|
36 hours maximum after the surgery
|
Concordance of respiratory rate value measured by 2 different devices after surgery
기간: 36 hours maximum after the surgery
|
Comparison between respiratory rate measured by conventional medical monitoring device and by connected patch
|
36 hours maximum after the surgery
|
Concordance of arterial oxygen saturation value measured by 2 different devices after surgery
기간: 36 hours maximum after the surgery
|
Comparison between arterial oxygen saturation measured by conventional medical monitoring device and by connected patch
|
36 hours maximum after the surgery
|
Concordance of temperature value measured by 2 different devices after surgery
기간: 36 hours maximum after the surgery
|
Comparison between temperature measured by conventional medical monitoring device and by connected patch
|
36 hours maximum after the surgery
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
---|---|---|
Concordance of blood pressure value measured by 2 different devices during surgery
기간: During surgery
|
Comparison between blood pressure measured by conventional medical monitoring device and by connected patch
|
During surgery
|
Concordance of heart rate value measured by 2 different devices during surgery
기간: During surgery
|
Comparison between heart rate measured by conventional medical monitoring device and by connected patch
|
During surgery
|
Concordance of respiratory rate value measured by 2 different devices during surgery
기간: During surgery
|
Comparison between respiratory rate measured by conventional medical monitoring device and by connected patch
|
During surgery
|
Concordance of arterial oxygen saturation value measured by 2 different devices during surgery
기간: During surgery
|
Comparison between arterial oxygen saturation measured by conventional medical monitoring device and by connected patch
|
During surgery
|
Concordance of temperature value measured by 2 different devices during surgery
기간: During surgery
|
Comparison between temperature value measured by conventional medical monitoring device and by connected patch
|
During surgery
|
Blood pressure artifact
기간: From surgery to 36 hours maximum after the surgery
|
Value of blood pressure will be considered as artifact if systolic blood pressure value < 80 or > 200 and diastolic blood pressure > 110
|
From surgery to 36 hours maximum after the surgery
|
Heart rate artifact
기간: From surgery to 36 hours maximum after the surgery
|
Value of heart rate will be considered as artifact if value < 40 or > 140
|
From surgery to 36 hours maximum after the surgery
|
Respiratory rate artifact
기간: From surgery to 36 hours maximum after the surgery
|
Value of respiratory rate will be considered as artifact if value < 8 or > 36
|
From surgery to 36 hours maximum after the surgery
|
Arterial oxygen saturation artifact
기간: From surgery to 36 hours maximum after the surgery
|
Value of arterial oxygen saturation will be considered as artifact if value < 85 %
|
From surgery to 36 hours maximum after the surgery
|
Acceptability of connected patch: numerical scale
기간: During the surgery and through study completion
|
Evaluation of connected patch with a simple numerical scale between 0 and 10: 0 representing a very poor tolerance of the device and leading to premature interruption of the collection and 10 a perfect tolerance allowing the patch to be maintained for several consecutive days
|
During the surgery and through study completion
|
공동 작업자 및 조사자
스폰서
수사관
- 수석 연구원: Morgan Le Guen, Hôpital Foch
연구 기록 날짜
연구 주요 날짜
연구 시작 (예상)
기본 완료 (예상)
연구 완료 (예상)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
기타 연구 ID 번호
- 2017055F
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
미국에서 제조되어 미국에서 수출되는 제품
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
패치 검증에 대한 임상 시험
-
LifeWatch Services, Inc.완전한
-
Yonsei University모병
-
Universitaire Ziekenhuizen KU LeuvenByteflies모집하지 않고 적극적으로
-
Yonsei University아직 모집하지 않음75세 이상의 고령자 또는 뇌졸중 위험이 높은 사람을 대상으로 MEMO Patch PLUS를 사용하여 1일 대 8일 이상 심방 세동 감지를 평가하는 임상 시험 (MEMO-DAF8)뇌졸중 위험이 높은 환자의 심방세동/조동대한민국
-
Population Health Research InstituteCanadian Cardiovascular Society; Canadian Stroke Prevention Intervention Network완전한
-
Massachusetts General HospitalThe Hospital for Sick Children; National Institute of Diabetes and Digestive and Kidney...완전한
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)모병악성 고형 신생물 | 흑색종 | 대장염 | 폐 비소세포 암종 | 악성 비뇨생식기계 신생물미국
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)모병악성 고형 신생물 | 대장염 | IVA기 폐암 AJCC v8 | IVB기 폐암 AJCC v8 | 폐 비소세포 암종 | 3기 폐암 AJCC v8 | IV기 폐암 AJCC v8 | II기 폐암 AJCC v8 | IIA기 폐암 AJCC v8 | IIB기 폐암 AJCC v8 | IIIA기 폐암 AJCC v8 | IIIB기 폐암 AJCC v8 | 임상 3기 피부 흑색종 AJCC v8 | 병리학적 병기 IIIB 피부 흑색종 AJCC v8 | 병리학적 병기 IIIC 피부 흑색종 AJCC v8 | 병리학적 병기 IIID 피부 흑색종 AJCC v8 | 임상 0기 피부 흑색종 AJCC v8 | 임상 1기 피부 흑색종... 그리고 다른 조건미국